Faculty

Institution

Unit

Venue

Jessica M. Stempel, M.D., M.H.S., FACP

Assistant Professor of Medicine Division of Hematology/Medical Oncology School of Medicine

Oregon Health & Science University

Affiliations

Center For Hematologic Malignancies

Jessica M. Stempel, M.d., M.h.s., Facp is currently serving as a Center For Hematologic Malignancies Assistant Professor of Medicine Division of Hematology/Medical Oncology School of Medicine at Oregon Health & Science University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Jessica M. Stempel, M.D., M.H.S., FACP

Oregon Health & Science University

Assistant Professor of Medicine Division of Hematology/Medical Oncology School of Medicine

You can click a keyword to filter the displayed items

medicine hematology oncology leukemia hematological malignancies cancer care myeloid neoplasia clinical research pharmacology clinical trials cancer treatment cancer research health sciences aplastic anemia thrombosis pharmacotherapy older patients radiation oncology lymphoid neoplasia hemostasis clinical epidemiology malignant blood disorders myelodysplastic syndromes therapeutic targets medicinal research internal medicine cellular therapy clinical transplantation cancer education continuing medical education prognosis cancer disparities acute myeloid leukemia cancer immunotherapy blood purification cancer management clinical case presentation blood transfusion health profession training health care disparities leukemia clinical trials polycythemia vera essential thrombocythemia chronic myeloid leukemia podcast curriculum thoracic oncology medical mycology distance education vascular biology supportive care cancer cells health systems gastrointestinal oncology cancer biology medical statistics cancer risk disease management primary investigation cord blood novel therapies bone marrow failure treatment options colorectal cancer cancer screening general internal medicine combined modality treatment gender disparities pediatric hematology statin use population-based study birth characteristics current landscape myelodysplastic syndromes/neoplasms future directions ii trial novel targets

Notable Scholarly Works

Notable Federal Grants

Collaborators

Assessment of Fellowship Didactic Curricula in Hematology/Oncology: Cross-Sectional Findings From the Podcast-Hof Trial. Journal of Cancer Education (2026)

medicineinternal medicinecancer carehealth profession trainingnursingclinical evaluationcontinuing medical educationfellowship didactic curriculaoncologypodcast-hof trialradiologic educationmedical educationcross-sectional findings

Cost-Effectiveness of Frontline Eltrombopag With Immunosuppressive Therapy for Severe Aplastic Anemia. Blood Red Cells & Iron (2026)

blood donationimmunosuppressive therapymedicinehematologyhaematopoiesissevere aplastic anemiablood purificationfrontline eltrombopagbone marrow transplantationcritical careaplastic anemia

Examination of Gender Disparity in Research Presentations at an International Oncology Conference. JCO oncology advances. (2026)

sex rolescancer educationqualitative researchgender studiesgender disparityinternational oncology conferenceresearch presentationsgender inequalitygynecologywomen's healthgender diversitycancer disparities

Advances and Challenges in the Management of Myelodysplastic Syndromes. Cancers (2025)

hematological malignanciesmedicineleukemiamyeloid neoplasiahematologypharmacotherapypathologymyelodysplastic syndromesmolecular medicine

Calcineurin Inhibitor and Eltrombopag Combination for Acquired Aplastic Anemia: Results From a Large National Database. Therapeutic Advances in Hematology (2025)

medicinepharmacologycalcineurin inhibitorhematologypharmacotherapytherapeutic targetsclinical researchaplastic anemiaeltrombopag combination

Clinical Implications of Tp53 Mutations (Tp53Mt) in Patients (Pts) With Higher Risk Myelodysplastic Syndromes (Hr-Mds) Treated With Hypomethylating Agents (Hma) and Allogeneic Hematopoietic Transplantation (Allo-Hct): An Analysis From the International Consortium of Mds (Icmds) Validate Database. Blood (2025)

medicineleukemiatp53 mutationsmyeloid neoplasiahematologycancer researchoncologybone marrow transplantationclinical implicationscell transplantationinternational consortiumpathologyclinical transplantationstem cell transplantationmolecular medicine

Contemporary Understanding of Myeloid-Derived Suppressor Cells in the Acute Myeloid Leukemia (Aml) and Myelodysplastic Syndrome (Mds) Tumor Microenvironment. Expert Review of Anticancer Therapy (2025)

immunologyhematological malignanciescontemporary understandingleukemiamyeloid-derived suppressor cellsmyeloid neoplasiacancer researchacute myeloid leukemiacancer cellstumor microenvironmenttumor biologycell biology

Cost-Effectiveness of Upfront vs Delayed Allogeneic Hematopoietic Stem Cell Transplant for Intermediate Risk Aml. Blood Advances (2025)

medicineoutcomes researchleukemiacell therapyhematologystem cellsbone marrow transplantationcell transplantationintermediate risk amlgraft survivalstem cell transplantationhealth policy

Educational Impact of a Podcast Curriculum for Hematology/Oncology Fellows: Final Results of the Multicenter Cluster Randomized Podcast-Hof Trial. JCO Oncology Practice (2025)

medicinecancer carecancer educationhealth profession trainingeducationclinical trialscontinuing medical educationdistance educationeducational impactmedical educationfinal resultspodcast curriculum

Impact of Metformin on the Incidence of Thrombotic Events in Older Patients With Polycythemia Vera and Essential Thrombocythemia in the United States. Blood (2025)

medicineanticoagulantshematologythrombosisepidemiologyessential thrombocythemiapolycythemia verachronic diseasesunited statesvenous thrombosishealth sciences

1
2
3
4
5
6
10 / page

Jessica M. Stempel, M.D., M.H.S., FACP

Assistant Professor of Medicine Division of Hematology/Medical Oncology School of Medicine

Oregon Health & Science University

Affiliations

Center For Hematologic Malignancies

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Jessica M. Stempel, M.D., M.H.S., FACP

Oregon Health & Science University

Assistant Professor of Medicine Division of Hematology/Medical Oncology School of Medicine

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Assessment of Fellowship Didactic Curricula in Hematology/Oncology: Cross-Sectional Findings From the Podcast-Hof Trial. Journal of Cancer Education (2026)

Cost-Effectiveness of Frontline Eltrombopag With Immunosuppressive Therapy for Severe Aplastic Anemia. Blood Red Cells & Iron (2026)

blood donationimmunosuppressive therapymedicinehematologyhaematopoiesissevere aplastic anemiablood purificationfrontline eltrombopagbone marrow transplantationcritical careaplastic anemia

Examination of Gender Disparity in Research Presentations at an International Oncology Conference. JCO oncology advances. (2026)

Advances and Challenges in the Management of Myelodysplastic Syndromes. Cancers (2025)

hematological malignanciesmedicineleukemiamyeloid neoplasiahematologypharmacotherapypathologymyelodysplastic syndromesmolecular medicine

Calcineurin Inhibitor and Eltrombopag Combination for Acquired Aplastic Anemia: Results From a Large National Database. Therapeutic Advances in Hematology (2025)

medicinepharmacologycalcineurin inhibitorhematologypharmacotherapytherapeutic targetsclinical researchaplastic anemiaeltrombopag combination

Cost-Effectiveness of Upfront vs Delayed Allogeneic Hematopoietic Stem Cell Transplant for Intermediate Risk Aml. Blood Advances (2025)

medicineoutcomes researchleukemiacell therapyhematologystem cellsbone marrow transplantationcell transplantationintermediate risk amlgraft survivalstem cell transplantationhealth policy

Educational Impact of a Podcast Curriculum for Hematology/Oncology Fellows: Final Results of the Multicenter Cluster Randomized Podcast-Hof Trial. JCO Oncology Practice (2025)

medicinecancer carecancer educationhealth profession trainingeducationclinical trialscontinuing medical educationdistance educationeducational impactmedical educationfinal resultspodcast curriculum

Impact of Metformin on the Incidence of Thrombotic Events in Older Patients With Polycythemia Vera and Essential Thrombocythemia in the United States. Blood (2025)

medicineanticoagulantshematologythrombosisepidemiologyessential thrombocythemiapolycythemia verachronic diseasesunited statesvenous thrombosishealth sciences

1
2
3
4
5
6
10 / page